Other News To Note

April 2013
BioWorld International;4/17/2013, Vol. 18 Issue 16, p2
This section presents news briefs related to biotechnology companies. Atox Bio Ltd. revealed that the administration of a single dose of AB103 increased survival in animals and reduced tissue necrosis and inflammation. Avilex Pharma ApS received seed funding from Novo Seeds for the development of dimeric ligands targeting PDZ domains. The U.S. government issued a regulatory approval for BioLineRx Ltd. to begin a Phase IIa trial of BL-8040 selective antagonist of chemokine receptor CXCR4.


Related Articles

  • Financings Roundup.  // BioWorld Today;12/20/2011, Vol. 22 Issue 244, p2 

    This section offers news briefs on biotechnology industry financing as of December 2012, including the 3.25 million U.S. dollars raised by Atox Bio Inc. The second tranche of a 22.5 million Canadian dollar private placement by Philip Morris Investments BV was closed by Medicago Inc. A private...

  • Financings Roundup. Powers, Marie // BioWorld Today;4/16/2013, Vol. 24 Issue 72, p9 

    The article reports on seed funding received by Danish pharmaceutical company Avilex Pharma ApS from Novo Seeds, which will be used to support the development of dimeric ligands that target PDZ domains.

  • Other News To Note.  // BioWorld International;11/28/2012, Vol. 17 Issue 48, p4 

    This section offers news briefs on the biotechnology industry as of November 28, 2012. A research collaboration has been signed by Ablynx NV and Algeta ASA to evaluate a targeted thorium conjugate. Activiomics Ltd. entered a research agreement with Kyowa Hakko Kirin of Japan. Atox Bio Ltd....

  • OTHER NEWS TO NOTE.  // BioWorld International;7/1/2009, Vol. 14 Issue 26, p2 

    This section offers news briefs on the biotechnology industry. An advance has been made by Ark Therapeutics Group PLC in the production technology and manufacturing processes for its adenoviral gene therapies. A joint research and development (R&D) program has been formed by Atox Bio Ltd. and...

  • Other News To Note.  // BioWorld Today;10/26/2011, Vol. 22 Issue 208, p6 

    This section offers news briefs on the biopharmaceutical industry. A license agreement was entered between Acton Pharmaceuticals Inc. and Sanofi U.S. An oprphan drug designation was granted by the U.S. Food and Drug Administration (FDA) for Atox Bio Inc.'s ABI03 for necrotizing soft tissue...

  • Other News To Note.  // BioWorld International;5/18/2011, Vol. 16 Issue 20, p3 

    This section offers news briefs on the biotechnology industry. Agendia BV of the Netherlands, AstraZenca Plc of England and the Netherlands Cancer Institute partnered to facilitate the development of medicines for the treatment of different types of colorectal cancer. Israel-based Atox Bio Inc....

  • NEWS EUROPEAN DIGEST.  // AV Magazine;Jun/Jul2013, p4 

    The article offers news briefs from European countries as of June 1, 2013. Topics discussed including partnership of the audiovisual system integrator Avilex, the consultant Envision Group and the firm Mitsubishi Electric for creating modern trading centre; creation of space shuttle experience...

  • Other News To Note.  // BioWorld Today;9/11/2012, Vol. 23 Issue 176, p2 

    This section offers news briefs on the biotechnology industry as of September 11, 2012. AmpliPhi Biosciences Corp. has made an offer to buy Special Phage Services (SPS). Arsanis Biosciences GmbH received two grants involving the Austrian Research Promotion Agency. The U.S. Food and Drug...

  • Financings Roundup.  // BioWorld Today;2/29/2012, Vol. 23 Issue 40, p7 

    This section offers news briefs on financing for companies in the biotechnology sector, including the 15 million U.S. dollar private placement closed by BioLine Rx Ltd. with U.S. institutional investors and the Series B preferred unit private equity financing closed by Eleison Pharmaceuticals LLC.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics